Evidence map›Paper›PMID 39767807›Full record

ArticleBiomedicines2024

Proximity Proteomics Reveals USP44 Forms a Complex with BRCA2 in Neuroblastoma Cells and Is Required to Prevent Chromosome Breakage.

Asma Ali, Sajjad Hussain, Tibor Bedekovics, Raymond H Jeon, Danielle G May, Kyle J Roux, Paul J Galardy

Abstract read
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Asma AliDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0009-0007-7686-4824
Sajjad HussainDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Tibor BedekovicsDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0009-0003-9027-2324
Raymond H JeonDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Danielle G MayEnabling Technology Group, Sanford Research, Sioux Falls, SD 57104, USA.ORCID 0000-0002-2628-4414
Kyle J RouxEnabling Technology Group, Sanford Research, Sioux Falls, SD 57104, USA.ORCID 0000-0001-7530-5528
Paul J GalardyDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Funding

Yeast 2 HybridP20GM103620 · NIGMS · SANFORD RESEARCH/USD · PI ROUX, KYLE J · 2013 to 2023
$24.2M
Hyundai Hope On Wheels Not applicableMayo Clinic Not applicableNIGMS NIH HHS P20 GM103620
6 · The paper itself

Abstract

BACKGROUND/

objectivesThe enzyme ubiquitin-specific protease 44 (USP44) is a deubiquitinating enzyme with identified physiological roles as a tumor suppressor and an oncogene. While some binding partners and substrates are known for USP44, the identification of other interactions may improve our understanding of its role in cancer. We therefore performed a proximity biotinylation study that identified products of several known cancer genes that are associated with USP44, including a novel interaction between BRCA2 and USP44.

methodsWe expressed a fusion protein that linked USP44 and mutant Escherichia coli biotin ligase BioID in SH-SY5Y neuroblastoma cells. Control experiments were performed using BioID alone. In duplicate experiments, cells were pulsed with biotin and biotinylated proteins were isolated under denaturing conditions and the proteins were identified by mass spectrometry. The resulting list of proteins were analyzed using Enrichr and cross-referenced with the COSMIC Cancer Gene Census. We validated the association with BRCA2 using immunoprecipitation. The role of USP44 in the Fanconi anemia DNA repair pathway was investigated using chromosome analysis of wild-type or Usp44-knockout cells after exposure to mitomycin C.

resultsWe identified 146 proteins that were selectively retrieved by the USP44 construct and compared with cells expressing the BioID ligase alone, including 15 gene products encoded by genes on tier 1 of the COSMIC Cancer Gene Census, including BRCA2. The association between USP44 and BRCA2 was validated through immunoprecipitation. We tested the functional role of USP44 in the Fanconi anemia DNA repair pathway through chromosome breakage analysis and found that cells lacking USP44 had a significant increase in chromosome breaks and radial chromosomes. We found that high

conclusionsOur results identified novel potential binding partners and potential substrates for USP44, including several with direct roles in cancer pathogenesis. Our results identified a novel association between BRCA2 and USP44, and a previously unknown role for USP44 in the Fanconi anemia DNA repair pathway that may contribute to its role in cancer.

Indexed as

Fanconi anemianeuroblastomaproteomicsubiquitin

Identifiers

PMID39767807
PMCPMC11727000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.